MedPath

A randomised controlled study of continuous subcutaneous insulin infusion (CSII) therapy compared to conventional bolus insulin treatment in preschool aged children with Type 1 diabetes. - n/a

Phase 1
Conditions
Type 1 Diabetes Mellitus
Registration Number
EUCTR2005-004526-72-GB
Lead Sponsor
Addenbrooke's NHS Trust
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Recruiting
Sex
Not specified
Target Recruitment
20
Inclusion Criteria

Inclusion Criteria
i. Newly diagnosed Type 1 diabetes mellitus
ii. Age at diagnosis < 3.99 years

Are the trial subjects under 18? yes
Number of subjects for this age range:
F.1.2 Adults (18-64 years) no
F.1.2.1 Number of subjects for this age range
F.1.3 Elderly (>=65 years) no
F.1.3.1 Number of subjects for this age range

Exclusion Criteria

i. Neurological disability / handicap e.g. Cerebral palsy
ii. Gastrointestinal disease
iii. Chronic illness other than T1DM that may affect conduct of study

Study & Design

Study Type
Interventional clinical trial of medicinal product
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath